BTK and diffuse large B-cell lymphoma: By recreating these unique mutations using CRISPR/Cas9 gene editing in BTK along with transduction into DLBCL cells, Yuan et al. targeted several key genes involved in BCR signaling pathways using signal-guide RNAs (sgRNAs).